Protocol for the P3BEP trial (ANZUP 1302): an international randomised phase 3 trial of accelerated versus standard BEP chemotherapy for adult and paediatric male and female patients with intermediate and poor-risk metastatic germ cell tumours

BACKGROUND: Bleomycin, etoposide, and cisplatin (BEP) chemotherapy administered every 3 weeks for 4 cycles remains the standard first line treatment for patients with intermediate- and poor-risk metastatic germ cell tumours (GCTs). Administering standard chemotherapy 2-weekly rather than 3-weekly, s...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:BMC Cancer
Huvudupphovsmän: Lawrence, Nicola J., Chan, Howard, Toner, Guy, Stockler, Martin R., Martin, Andrew, Yip, Sonia, Wong, Nicole, Yeung, Annie, Mazhar, Danish, Pashankar, Farzana, Frazier, Lindsay, McDermott, Ray, Walker, Roderick, Tan, Hsiang, Davis, Ian D., Grimison, Peter
Materialtyp: Artigo
Språk:Inglês
Publicerad: BioMed Central 2018
Ämnen:
Study Protocol
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6114870/
https://ncbi.nlm.nih.gov/pubmed/30157803
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-018-4745-3
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk